Scholar Rock welcomes Dr. Katie Peng to its Board of Directors
– USA, MA – Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, and cardiometabolic disorders, today announced the appointment of Katie Peng to its Board of Directors.…